These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34514920)

  • 1. Considerations regarding noncredible performance in the neuropsychological assessment of patients with multiple sclerosis: A case series.
    Sanborn V; Lace J; Gunstad J; Galioto R
    Appl Neuropsychol Adult; 2023; 30(4):458-467. PubMed ID: 34514920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Clinical Utility of Selected Memory-Based Embedded Performance Validity Tests in Neuropsychological Assessment of Patients with Multiple Sclerosis.
    Lace JW; Merz ZC; Galioto R
    Neurol Int; 2021 Sep; 13(4):477-486. PubMed ID: 34698256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric validity assessment.
    Kirkwood MW
    NeuroRehabilitation; 2015; 36(4):439-50. PubMed ID: 26409492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmemory Composite Embedded Performance Validity Formulas in Patients with Multiple Sclerosis.
    Lace JW; Merz ZC; Galioto R
    Arch Clin Neuropsychol; 2022 Feb; 37(2):309-321. PubMed ID: 34467368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for the MS-CEBA study: an observational, prospective cohort study identifying Cognitive, Energetic, Behavioural and Affective (CEBA) profiles in Multiple Sclerosis to guide neuropsychological treatment choice.
    Reinhardt A; Rakers SE; Heersema DJ; Beenakker EAC; Meilof JF; Timmerman ME; Spikman JM
    BMC Neurol; 2024 Jun; 24(1):224. PubMed ID: 38943063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the Modified Somatic Perception Questionnaire (MSPQ) in a large sample of credible and noncredible patients referred for neuropsychological testing.
    Balasanyan M; Boone KB; Ermshar A; Miora D; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Clin Neuropsychol; 2018 Jan; 32(1):165-182. PubMed ID: 28585455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
    Jackson DA; Nicholson R; Bergmann C; Wilken J; Kaczmarek O; Bumstead B; Buhse M; Zarif M; Penner IK; Hancock LM; Golan D; Doniger GM; Bogaardt H; Barrera M; Covey TJ; Gudesblatt M
    Mult Scler Relat Disord; 2023 Jan; 69():104410. PubMed ID: 36399966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members.
    Mooney SR; Stafford J; Seats E
    Mil Med; 2018 Nov; 183(11-12):e546-e554. PubMed ID: 29590406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embedded performance validity testing in neuropsychological assessment: Potential clinical tools.
    Rickards TA; Cranston CC; Touradji P; Bechtold KT
    Appl Neuropsychol Adult; 2018; 25(3):219-230. PubMed ID: 28139144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncredible effort during pediatric neuropsychological exam: a case series and literature review.
    Kirkwood MW; Kirk JW; Blaha RZ; Wilson P
    Child Neuropsychol; 2010; 16(6):604-18. PubMed ID: 20628928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.
    El-Wahsh S; Balandin S; Bogaardt H; Kumfor F; Ballard KJ
    Int J Lang Commun Disord; 2022 May; 57(3):680-694. PubMed ID: 35338749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of functional impairment ratings to noncredible reporting in postsecondary students undergoing screening for ADHD.
    Suhr JA; Lee GJ; Harrison AG
    Clin Neuropsychol; 2022 Aug; 36(6):1493-1505. PubMed ID: 32924813
    [No Abstract]   [Full Text] [Related]  

  • 16. What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
    Magnin E; Sagawa Y; Moulin T; Decavel P
    Eur Neurol; 2020; 83(3):263-270. PubMed ID: 32634812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of performance and symptom validity testing with pediatric populations.
    Kirk JW; Baker DA; Kirk JJ; MacAllister WS
    Appl Neuropsychol Child; 2020; 9(4):292-306. PubMed ID: 32372667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French validation of the Brief International Cognitive Assessment for Multiple Sclerosis.
    Maubeuge N; Deloire MSA; Brochet B; Erhlé N; Charré-Morin J; Saubusse A; Ruet A;
    Rev Neurol (Paris); 2021; 177(1-2):73-79. PubMed ID: 32713736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Norma Latina neuropsychological assessment battery in individuals with multiple sclerosis in Mexico.
    Rivera D; Ramos Usuga D; Fuentes Mendoza EM; Aguayo Arelis A; Rabago Barajas BV; Macías Islas MÁ; Krch D; Lequerica AH; Arango-Lasprilla JC
    Mult Scler Relat Disord; 2022 Mar; 59():103685. PubMed ID: 35196609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttraumatic stress disorder and noncredible symptom reporting on the Trauma Symptom Inventory-2.
    Henry GK; Gornbein J
    Appl Neuropsychol Adult; 2022; 29(1):100-105. PubMed ID: 31923365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.